Self-sterilizing medical devices market set to hit $1.88 billion by 2030

A new market report says demand for self-sterilizing medical devices is rising as hospitals seek better infection control and fewer cross-contamination risks. The market is projected to grow from $0.98 billion in 2025 to $1.11 billion in 2026, then reach $1.88 billion by 2030.

Why it matters: - Self-sterilizing medical devices are moving from niche technology to a broader infection-prevention tool in healthcare settings. - The market’s growth reflects pressure on hospitals to reduce hospital-acquired infections, improve surgical hygiene and support safer reuse of medical instruments. - Faster adoption could help lower cross-contamination risks in operating rooms, wards and other clinical workflows.

What happened: - The Business Research Company released a report on the self-sterilizing medical devices market on July 22, 2026. - The report estimates the market will grow from $0.98 billion in 2025 to $1.11 billion in 2026. - The report projects the market will reach $1.88 billion by 2030. - The report says North America held the largest regional share in 2025. - The report says Asia-Pacific is expected to post the fastest growth during the forecast period. - Download a free sample of the report. - View the full report.

The details: - Self-sterilizing medical devices use built-in technologies to reduce or eliminate microbial contamination without external sterilization methods. - Common approaches include antimicrobial coatings, ultraviolet light and self-cleaning surface technologies. - The report ties historic growth to rising hospital-acquired infections, stronger surgical hygiene standards, increased use of reusable medical instruments, hospital infrastructure growth in emerging economies and early adoption of antimicrobial coatings. - The forecast period is supported by self-disinfecting materials, demand for autonomous infection-prevention systems, more minimally invasive surgeries, better healthcare infrastructure in developing regions and efforts to reduce cross-contamination. - The report highlights UV-C embedded sterilization in reusable instruments, advances in antimicrobial coatings, stricter infection-prevention protocols, more regulatory validation requirements and biocompatible self-disinfecting surfaces as major trends. - The report says hospital-acquired infections are a major growth driver because self-sterilizing devices can continuously reduce contamination on surfaces. - In Australia, the Australian Institute of Health and Welfare reported in November 2024 that hospital-acquired complications affected 115,000 public hospitalizations, or 2.0%, and 34,200 private hospitalizations, or 0.8%, during 2022–23. - Healthcare-associated infections accounted for 37% of those complications, making them the most frequent issue in that dataset. - The report says growing surgical volumes are another growth catalyst because self-sterilizing devices can reduce microbial contamination on instruments, surfaces and medical textiles. - Intuitive Surgical said in its 2024 annual report that about 2,683,000 surgeries were performed using da Vinci systems in early 2024, compared with 2,286,000 in 2023 and 1,875,000 in 2022. - The report says rising healthcare expenditure should also support adoption of advanced infection-control technology. - The Centers for Medicare and Medicaid Services said U.S. healthcare spending rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person.

Between the lines: - The report points to a market shaped by both clinical urgency and operational efficiency. - Hospitals want fewer infections, but they also face pressure to reduce dependence on manual sterilization steps and repeated instrument processing. - The regional split suggests the market is already established in mature healthcare systems while newer capacity and infrastructure spending may drive faster gains in Asia-Pacific.

What's next: - The report expects self-sterilizing technologies to gain from more autonomous infection-prevention systems and continued use of reusable devices. - Future adoption will likely track regulatory scrutiny around validation, especially for devices that promise built-in sterilization performance. - The report’s outlook implies stronger demand for products that combine infection control with long-term clinical durability.

The bottom line: - Self-sterilizing medical devices are becoming a practical response to persistent infection-control challenges, and the market is projected to nearly double by 2030.